Search results for "Atrioventricular Block"

showing 10 items of 20 documents

Cardiac kinematic parameters computed from video of in situ beating heart

2017

AbstractMechanical function of the heart during open-chest cardiac surgery is exclusively monitored by echocardiographic techniques. However, little is known about local kinematics, particularly for the reperfused regions after ischemic events. We report a novel imaging modality, which extracts local and global kinematic parameters from videos of in situ beating hearts, displaying live video cardiograms of the contraction events. A custom algorithm tracked the movement of a video marker positioned ad hoc onto a selected area and analyzed, during the entire recording, the contraction trajectory, displacement, velocity, acceleration, kinetic energy and force. Moreover, global epicardial veloc…

Malemedicine.medical_specialtyBeating heartSystoleVideo RecordingCardiac kinematic parametersFOS: Physical sciencesMyocardial ReperfusionKinematics030204 cardiovascular system & hematologyQuantitative Biology - Quantitative MethodsArticleDisplacement (vector)03 medical and health sciencesAcceleration0302 clinical medicineDiastoleInternal medicinemedicineAnimalsHumansComputer Simulation030212 general & internal medicineCoronary Artery BypassAtrioventricular BlockTissues and Organs (q-bio.TO)Quantitative Methods (q-bio.QM)PhysicsLive videoMultidisciplinaryopen-chest cardiac surgeryReproducibility of ResultsQuantitative Biology - Tissues and OrgansHeartPhysics - Medical Physicscontact-free and non-invasive modeMyocardial ContractionBiomechanical PhenomenaRatsCardiac surgeryCardiac kinematic parameters open-chest cardiac surgery contact-free and non-invasive modemedicine.anatomical_structureParticle image velocimetryFOS: Biological sciencesCardiologyFemaleMedical Physics (physics.med-ph)RheologyArteryScientific Reports
researchProduct

Permanent Pacemaker Lead Insertion Connected to an External Pacemaker Generator for Temporary Pacing After Transcatheter Aortic Valve Implantation.

2019

Abstract Background Outcomes after transcatheter aortic valve implantation (TAVI) have been demonstrated to be at least equivalent in the short term compared to surgical valve implantation (SAVI). However, Conduction abnormalities are more common after TAVI than SAVI and the need for permanent pacemaker implantation is more common after TAVI with the currently commercially available self-expanding valves than after SAVI. Temporary pacemaker implantation may be associated with inability to ambulate, lead migration or perforation and infection. Depending on the monitoring system, some arrhythmias may not be detected. We examined the feasibility and safety of permanent pacemaker lead implantat…

Malemedicine.medical_specialtyPacemaker ArtificialPerforation (oil well)Context (language use)030204 cardiovascular system & hematologySingle CenterPericardial effusionRisk AssessmentTranscatheter Aortic Valve Replacement03 medical and health sciences0302 clinical medicineElectric Power SuppliesRisk FactorsmedicineHumans030212 general & internal medicineLead (electronics)AgedRetrospective StudiesAged 80 and overbusiness.industryCardiac Pacing ArtificialAtrial fibrillationArrhythmias CardiacGeneral MedicineEquipment Designmedicine.diseaseSurgeryTreatment OutcomeFeasibility StudiesFemalePatient SafetyPermanent pacemakerCardiology and Cardiovascular MedicinebusinessAtrioventricular blockCardiovascular revascularization medicine : including molecular interventions
researchProduct

Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial

2014

BACKGROUND: In patients with relapsing-remitting MS (RRMS) fingolimod prevents disease relapses and delays disability progression. First dose administration of fingolimod is associated with a transient, dose-dependent decrease in heart rate (HR) in the 6 hours after drug intake.The aim of the study is to to assess safety and tolerability of the first dose of fingolimod in a cohort of Italian patients with RRMS without alternative therapeutic options. METHODS: Open-label, single arm, multicentre study. After the first dose of fingolimod, patients were observed for 6 hours and had their vital signs monitored hourly. Extended on-site monitoring was provided when required. RESULTS: Of the 906 p…

OncologyMaleNeurologyfingolimod multiple sclerosis treatment first dose safetyadministration /&/ dosage/adverse effects/analogs /&/ derivatives/therapeutic useImmunosuppressive AgentSphingosineMultiple SclerosiAtrioventricular Blockadministration /&/ dosage/adverse effects/therapeutic useGeneral MedicineMiddle AgedTolerabilityPropylene GlycolFingolimoddrug therapyTolerabilityAnesthesiaCohortAdolescent Adult Atrioventricular Block; chemically induced/epidemiology Drug Therapy; Combination Female Humans Immunosuppressive Agents; administration /&/ dosage/adverse effects/therapeutic use Male Middle Aged Multiple Sclerosis; drug therapy Propylene Glycols; administration /&/ dosage/adverse effects/therapeutic use Sphingosine; administration /&/ dosage/adverse effects/analogs /&/ derivatives/therapeutic use Young AdultCombinationDrug Therapy CombinationSettore MED/26 - NeurologiaFemaleAtrioventricular block; Bradycardia; Fingolimod; Multiple sclerosis; Safety; Tolerability; Adolescent; Adult; Atrioventricular Block; Drug Therapy Combination; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis; Propylene Glycols; Sphingosine; Young Adult; Neurology (clinical)SafetyAtrioventricular block Bradicardia Multiple sclerosis Fingolimod Safety TolerabilityImmunosuppressive AgentsResearch ArticleHumanmedicine.drugAdultmedicine.medical_specialtyMultiple SclerosisAdolescentClinical NeurologyYoung AdultFingolimod HydrochlorideInternal medicineBradycardiamedicineHumansNeurochemistryFingolimod Hydrochloridebusiness.industryMultiple sclerosisFingolimodmedicine.diseaseClinical trialPropylene GlycolsAtrioventricular block Bradycardia Multiple sclerosis Fingolimod Safety Tolerabilitychemically induced/epidemiologyNeurology (clinical)business
researchProduct

Die Wirkung von Ouabain auf die Elimination von Noradrenalin aus der Perfusionsfl�ssigkeit des isolierten Kaninchenherzens

1966

Isolated rabbit hearts were perfused with Tyrode solution containing 10 ng/ml (-)-noradrenaline for 20 min. The uptake by the heart of noradrenaline was calculated by estimating the percentage of amine removed from the perfusion fluid during a single passage through the heart. Previous experiments have shown that the amount of noradrenaline removed from the perfusion fluid corresponds well to the amount retained by the heart. In control experiments, the mean removal (elimination) of noradrenaline was 50±1.7% of the amount infused as measured biologically and 46±2.2% as measured fluorimetrically. Ouabain was added to the perfusion fluid at concentrations ranging from 2.74·10−7 to 2.0·10−6 mo…

PharmacologyInotropemedicine.medical_specialtyPotassiumNoradrenaline transportSodiumchemistry.chemical_elementGeneral Medicinemedicine.diseaseOuabainCell membraneEndocrinologymedicine.anatomical_structurechemistryInternal medicineMolemedicineAtrioventricular blockmedicine.drugNaunyn-Schmiedebergs Archiv f�r Pharmakologie und Experimentelle Pathologie
researchProduct

A G613A missense in the Hutchinson's progeria lamin A/C gene causes a lone, autosomal dominant atrioventricular block.

2014

Background LMNA/C mutations have been linked to the premature aging syndrome Hutchinson’s progeria, dilated cardiomyopathy 1A, skeletal myopathies (such as the autosomal dominant variant of Emery-Dreifuss muscular dystrophy and limb-girdle muscular dystrophy), Charcot-Marie-Tooth disorder type 2B1, mandibuloacral dysplasia, autosomal dominant partial lipodystrophy, and axonal neuropathy. Atrioventricular block (AVB) can be associated with several cardiac disorders and it can also be a highly heritable, primitive disease. One of the most common pathologies associated with AVB is dilated cardiomyopathy (DCM), which is characterized by cardiac dilatation and reduced systolic function. In this …

ProbandGeneticsExome sequencingAgingProgeriaLamin A/Cbusiness.industryResearchImmunologyDilated cardiomyopathymedicine.diseaseSudden deathLMNAMandibuloacral dysplasiaAgeingMedicineMissense mutationMuscular dystrophybusinessExome sequencingArrhythmiaAtrioventricular blockImmunityageing : IA
researchProduct

A rare case report of variable degrees of atrioventricular block during atrioventricular nodal reentrant tachycardia

2020

Tachycardiamedicine.medical_specialtybusiness.industrymedicine.medical_treatmentAblationAblationmedicine.diseaseHigh-degree atrioventricular blockReentrancyFunctional blockInternal medicineRC666-701Rare caseCase reportmedicineCardiologyAVNRTDiseases of the circulatory (Cardiovascular) systemmedicine.symptomCardiology and Cardiovascular MedicineNODALbusinessAtrioventricular nodal reentrant tachycardiaAtrioventricular blockHeartRhythm Case Reports
researchProduct

Chronisches thromboembolisches Cor pulmonale bei schrittmacherassoziierten rechtsatrialen Thromben: Pulmonale Thrombendarteriektomie mit Elektrodenen…

2008

Life-threatening chronic cor pulmonale occurred in a 22-year-old woman with congenital 3 degrees atrioventricular block, 6 years after implantation of a pacemaker and 3 1/2 years after removal of the pacemaker (the electrodes were too firmly attached to be removed). The emboli originated from the right-atrial thrombi which had formed around the electrodes left in situ. The embolic source shrank during systemic administration of urokinase, initially 600,000 IU in 60 min, then 100,000 IU per hour, and pulmonary perfusion improved transiently. Nonetheless the patient became breathless on the slightest physical exertion. Recurrent syncopal attacks with marked increase of pulmonary artery pressu…

Urokinasemedicine.medical_specialtyPulmonary thromboendarterectomybusiness.industrymedicine.medical_treatmentGeneral Medicinemedicine.diseaseRight atrialInternal medicinemedicine.arteryPulmonary arterymedicineCardiologyExertionbusinessAtrioventricular blockPerfusionmedicine.drugEndarterectomyDMW - Deutsche Medizinische Wochenschrift
researchProduct

A second-degree atrioventricular block with double escape rhythm secondary to paroxysmal vagal hypertonia.

2017

medicine.diagnostic_testbusiness.industryVagus NerveGeneral Medicine030204 cardiovascular system & hematologyMiddle Agedmedicine.diseaseVagus nerve03 medical and health sciencesElectrocardiography0302 clinical medicineRhythmAnesthesiaMedicineHypertoniaHumans030212 general & internal medicinemedicine.symptomCardiology and Cardiovascular MedicinebusinessAtrioventricular BlockAtrioventricular blockElectrocardiographySecond-degree atrioventricular blockJournal of cardiovascular medicine (Hagerstown, Md.)
researchProduct

The Role of Cardiac Pacing in Heart Block Complicating Acute Myocardial Infarction

1983

The organization of the Coronary Care Unit and the use of electrocardiographic monitoring have allowed a re-evaluation of the incidence of the atrioventricular conduction disturbances in acute myocardial infarction.

medicine.medical_specialtyCardiac pacingHeart blockbusiness.industryIncidence (epidemiology)Electrocardiography in myocardial infarctionmedicine.diseaseInternal medicinecardiovascular systemmedicineCardiologyCoronary care unitcardiovascular diseasesMyocardial infarctionbusinessAtrioventricular conduction disturbancesAtrioventricular block
researchProduct

BASCULE syndrome associated with presyncopal episodes and first‐degree atrioventricular block

2021

medicine.medical_specialtybusiness.industryMEDLINESyndromeDermatologymedicine.diseaseElectrocardiographyText miningFirst-degree atrioventricular blockInternal medicinemedicineCardiologyHumansAtrioventricular BlockbusinessInternational Journal of Dermatology
researchProduct